# Opella Healthcare International SAS – FDA Inspection, Jun 23, 2017

Source: https://www.keypedia.com/records/fda_inspections/opella-healthcare-international-sas/1b0f4f62-7248-47ac-89a2-45df0bbf81a3
Source feed: FDA_Inspections

> FDA inspection 1015497 of Opella Healthcare International SAS, June 23, 2017. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1015497
- Company Name: Opella Healthcare International SAS
- Inspection Date: 2017-06-23
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1268935 - 2025-01-10](https://www.keypedia.com/records/fda_inspections/opella-healthcare-international-sas/b8697760-87bc-469f-8b6c-8f8d68e8c532)
- FDA Inspection 1123990 - 2019-10-31
- [FDA Inspection 946883 - 2015-09-18](https://www.keypedia.com/records/fda_inspections/opella-healthcare-international-sas/e8f8ad70-e8e2-4f7d-b190-d3a9600b2da0)
- FDA Inspection 853427 - 2013-09-19
- [FDA Inspection 754638 - 2011-10-21](https://www.keypedia.com/records/fda_inspections/opella-healthcare-international-sas/6acc8514-a9b1-4dae-b00c-9d276858f948)

## Related Officers

- [Satheesh Thomas](https://www.keypedia.com/people/satheesh-thomas/8009b8a5-40f5-4791-b0e9-a7c855e3afd4)

Company: https://www.keypedia.com/companies/opella-healthcare-international-sas/53ed93ee-b631-49a0-bba2-a57194143394

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c